$16.64
chg
-0.41 (-2.40%)
quotes and stock data may be delayed 15 minutes
My Notes
Only BPIQ Pro members can create company notes. Learn more here.
52 wk low
8.99
52 wk hi
35.75
Cash
$283.0M
Burn Rate (Qtr)
$18.0M
Mkt Cap
$758.4m
Avg Volume
595,398
*cash/burn updated:
Q1 '22
Drug Pipeline
Click on drug name or indication to see upcoming trial info, prior data, and more general information.
No drug found
We don't have any drug data for this company yet
Drug | Disease (links)
Stage (next event)
Catalyst Date
Loading Catalysts...
search in progress
Pipeline powered by
PMVP
Company Profile
At PMV, we believe that by specifically targeting each mutant p53 we can fundamentally disrupt the course of cancer. Our research and development efforts are dedicated to selectively targeting mutant p53, providing unique therapies for any patient whose tumor harbors these gene mutations.
Recent Posts
See what the community is saying - click to see full post.